Hims & Hers: Sell-Off Opportunity
Out Fox The Street members get exclusive access to our real-world portfolios. See all of our investments here » Update - July 28, 2023 Cowen with a bull call on Hims with a price target of $11 after the stock recently traded at $12. Nice the greatest bull call, but it sure beats the short report. TD Cowen initiated its coverage of the digital healthcare platform Hims & Hers Health ( NYSE: HIMS ) with an Outperform rating and a $11 per share target on Friday, citing a disconnect between the company’s prospects and the valuation. Noting that Hims & Hers ( HIMS ) is set to expand at over 78% CAGR in 2019–2023E, analyst Jonna Kim argues that the company’s $1.2B revenue target for 2025, indicating over 22% CAGR, "implies a significant slowdown." Update - July 13, 2023 Kinda of a joke short report on Hims & Hers today, any stock could face a 25% hit. Heck, we view Apple as having the potential for 50% downside. The stock has bounced off strong suppor...